106 related articles for article (PubMed ID: 1577173)
21. Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat.
Nilsson O; Dahlström A; Grönstad KO; Rosengren L; Briving C; Skolnik G; Ahlman H
Acta Physiol Scand; 1984 Feb; 120(2):317-9. PubMed ID: 6711343
[No Abstract] [Full Text] [Related]
22. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments.
Stridsberg M; Hellman U; Wilander E; Lundqvist G; Hellsing K; Oberg K
J Endocrinol; 1993 Nov; 139(2):329-37. PubMed ID: 8308469
[TBL] [Abstract][Full Text] [Related]
23. Chromogranin A peptide-specific antisera and high-performance size exclusion chromatography demonstrate amino-terminal and carboxy-terminal fragments of the native molecule in human cell lines.
Brandt DW; Burton DW; Hogue-Angeletti R; Deftos LJ
Proc Soc Exp Biol Med; 1994 Apr; 205(4):316-20. PubMed ID: 8171054
[TBL] [Abstract][Full Text] [Related]
24. The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy.
Orr DF; Chen T; Johnsen AH; Chalk R; Buchanan KD; Sloan JM; Rao P; Shaw C
Proteomics; 2002 Nov; 2(11):1586-600. PubMed ID: 12442257
[TBL] [Abstract][Full Text] [Related]
25. Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum.
Watkinson A; Rogers M; Dockray GJ
Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):649-54. PubMed ID: 8240272
[TBL] [Abstract][Full Text] [Related]
26. Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin.
Udupi V; Lee HM; Kurosky A; Greeley GH
Regul Pept; 1999 Sep; 83(2-3):123-7. PubMed ID: 10511466
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous carcinoid tumour.
Courville P; Joly P; Thomine E; Ziade J; Soubrane JC; Kuhn JM; Lauret P
Histopathology; 2000 Jun; 36(6):566-7. PubMed ID: 10849101
[No Abstract] [Full Text] [Related]
28. Mass spectrometric identification of phosphorylated vasostatin II, a chromogranin A-derived protein fragment (1-113).
Zhang X; Dillen L; Bauer SH; Van Dongen W; Liang F; Przybylski M; Esmans E; De Potter WP; Claeys M
Biochim Biophys Acta; 1997 Dec; 1343(2):287-98. PubMed ID: 9434119
[TBL] [Abstract][Full Text] [Related]
29. Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Woussen-Colle MC; Gourlet P; Vandermeers A; Vandermeers-Piret MC; D'Haens J; Velkeniers B; Robberecht P
Peptides; 1995; 16(2):231-6. PubMed ID: 7784254
[TBL] [Abstract][Full Text] [Related]
30. Carcinoid tumour metastatic to the orbit with infiltration to the extraocular orbital muscle.
Borota OC; Kloster R; Lindal S
APMIS; 2005 Feb; 113(2):135-9. PubMed ID: 15723688
[TBL] [Abstract][Full Text] [Related]
31. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
32. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A,B and secretogranin II.
Prommegger R; Obrist P; Ensinger C; Schwelberger HG; Wolf C; Fischer-Colbrie R; Mikuz G; Bodner E
Anticancer Res; 1998; 18(6A):3999-4002. PubMed ID: 9891437
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
[TBL] [Abstract][Full Text] [Related]
35. Chromogranin A: posttranslational modifications in secretory granules.
Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
[TBL] [Abstract][Full Text] [Related]
36. Chromogranin A and its derived peptides in the rat and porcine gastro-entero-pancreatic system. Expression, localization, and characterization.
Curry WJ; Norlén P; Barkatullah SC; Johnston CF; Håkanson R; Hutton JC
Adv Exp Med Biol; 2000; 482():205-13. PubMed ID: 11192581
[No Abstract] [Full Text] [Related]
37. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
O'Connor DT; Deftos LJ
N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
[TBL] [Abstract][Full Text] [Related]
38. Management of midgut carcinoids.
Akerström G; Hellman P; Hessman O; Osmak L
J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
[TBL] [Abstract][Full Text] [Related]
39. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.
Arden SD; Rutherford NG; Guest PC; Curry WJ; Bailyes EM; Johnston CF; Hutton JC
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):521-8. PubMed ID: 8141763
[TBL] [Abstract][Full Text] [Related]
40. Clinical scenario 2: Exploring treatment options for patients with symptomatic, progressive GEP-NETs.
Pape UF
Clin Adv Hematol Oncol; 2014 Dec; 12(12 Suppl 19):20-2. PubMed ID: 25768106
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
